Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea FDA Mulls Detailed Biosimilar Guidelines To Boost Homegrown Firms

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Sensing big potential for the biosimilars segment, Korea FDA has embarked upon a plan to improve its guidelines on standardization and quality that can eventually enable its homegrown companies to develop a sizeable pipeline of biosimilar products. The agency intends to implement the guidelines in 2011

You may also be interested in...



With Samsung's Push For MabThera Biosimilar, Roche Persists On Call For Strengthened Regulatory Framework

SEOUL - In reaction to South Korean firm Samsung Electronics' recent clinical trial application for its biosimilar of Roche's MabThera, Roche said that it supports developing a regulatory framework for biosimilars that would apply the same stringent standards as those applied to originator products to ensure the protection of public health

With Samsung's Push For MabThera Biosimilar, Roche Persists On Call For Strengthened Regulatory Framework

SEOUL - In reaction to South Korean firm Samsung Electronics' recent clinical trial application for its biosimilar of Roche's MabThera, Roche said that it supports developing a regulatory framework for biosimilars that would apply the same stringent standards as those applied to originator products to ensure the protection of public health

South Korea To Strengthen Medical Equipment Sector

SEOUL - Ahead of the July 2011 launch of Korea-EU free trade agreement, which local observers fear could damage the local healthcare sector, the Korean government is hammering out a set of measures to help the country's medical equipment industry

Related Content

UsernamePublicRestriction

Register

LL038093

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel